SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001654954-17-004680
Filing Date
2017-05-15
Accepted
2017-05-15 10:38:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT camberamag201713g.htm SC 13G 62252
2 UNDERWRITING AGREEMENT AMAG13ga2017ex1filed.htm EX-1 4782
  Complete submission text file 0001654954-17-004680.txt   68603
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-38286 | Film No.: 17841998
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LLC (Filed by) CIK: 0001444043 (see all company filings)

IRS No.: 421693587 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G